Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Arena Pharmaceuticals (United States) | Researchclopedia

Back to institutions

Arena Pharmaceuticals (United States)

San Diego, Californiacompany

591

Works

118,022

Citations

142

h-index

Top Research Topics

Receptor Mechanisms and Signaling Diabetes Treatment and Management Pharmacology and Obesity Treatment

Top Researchers

Aviv Regev Broad Institute

964 works224,418 citationsh-index: 208

Recent Research

Targeting Pediatric Glioblastomas by Combining OLIG2 Inhibitor CT-179 with Fractionated Radiation in a Panel of Patient-Derived Orthotopic Xenograft Mouse Models

Holly Lindsay,Yuchen Du,et al.

20260 citations

Neuropeptides and Animal Physiology

Inflammatory Bowel Disease

Neurotransmitter Receptor Influence on Behavior

Sphingolipid Metabolism and Signaling

Cannabis and Cannabinoid Research

Cardiovascular and exercise physiology

Regulation of Appetite and Obesity

Biochemical Analysis and Sensing Techniques

Pulmonary Hypertension Research and Treatments

Gary G. Koch University of North Carolina at Chapel Hill

703 works118,841 citationsh-index: 87

Séverine Vermeire KU Leuven

2,394 works110,771 citationsh-index: 163

Carl J. Lavie University of New Orleans

1,662 works107,657 citationsh-index: 135

Laurent Peyrin‐Biroulet Délégation Centre-Est

2,078 works86,336 citationsh-index: 137

Frank McCormick Leidos (United States)

786 works80,567 citationsh-index: 130

Drug and single-cell gene expression integration identifies sensitive and resistant glioblastoma cell populations

Robert K. Suter,Anna M. Jermakowicz,et al.

20261 citations

Molecular docking—A solved problem?

J. Cole,E. Davis,et al.

20260 citations

The Selective Estrogen Receptor Degrader ZN-c5 Has Broad Antitumor Activity in Wild-Type and Mutant ER-Positive Breast Cancer Models

Jianhui Ma,Sayee G. Hegde,et al.

20250 citations

981P Enozertinib (ORIC-114), a highly selective, brain penetrant EGFR and HER2 inhibitor, in patients with HER2 Exon 20 mutant NSCLC: Randomized dose optimization

C-C. Lin,M.H. Hong,et al.

20250 citations

LBA13 Enozertinib (ORIC-114), a highly selective, brain penetrant EGFR and HER2 inhibitor, in EGFR Exon 20 mutant NSCLC: Randomized dose optimization and CNS activity

Thomas John,N. Mohindra,et al.

20250 citations